Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309
Condition(s):Advanced or Metastatic Solid TumorsLast Updated:November 18, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced or Metastatic Solid TumorsLast Updated:November 18, 2023Not yet recruiting
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:September 13, 2023Recruiting
Condition(s):Metastatic Triple-Negative Breast CancerLast Updated:November 18, 2023Recruiting
Condition(s):Recurrent GlioblastomaLast Updated:August 18, 2022Terminated
Condition(s):Recurrent GlioblastomaLast Updated:August 17, 2022Active, not recruiting
Condition(s):Triple Negative Breast CancerLast Updated:August 17, 2022Active, not recruiting
Condition(s):Recurrent GlioblastomaLast Updated:January 27, 2021Completed
Condition(s):Advanced Cancer; Metastatic CancerLast Updated:January 29, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.